Quick Answer
Niagen Bioscience, Inc. reported Long Term Debt of $0.00 for the year ending 2016.
- Niagen Bioscience, Inc. showed a decrease of -100.0% in Long Term Debt from 2015 to 2016.
- This data is from Niagen Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2017.
- XBRL data for this metric is available from 2014 to 2016 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $1.79 million | Q2 2015: $4.63 million | Q3 2015: $4.23 million | Q1 2016: $2.91 million | Q3 2016: $0.00.
- Over the full 3 years of available data (2014 to 2016), Niagen Bioscience, Inc.'s Long Term Debt has declined by 100.0%.
- Historical annual values: Fiscal year 2016: $0.00 | Fiscal year 2015: $3.35 million | Fiscal year 2014: $1.98 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: